AntriaBio
NASDAQ: RZLTLouisville, US · Founded 2010 · Nevada corporation · 1 known investors
Biotech
Founders & leadership
HH
Hoyoung HuhDirector, Executive Officer
SM
Sankaram MantripragadaExecutive Officer
NC
Nevan Charles ElamExecutive Officer, Director
BS
Barry ShermanDirector
ML
Morgan Lynn FieldsExecutive Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$41MraisedOct 2020 · 12 investors · BiotechnologyRule 506(b)
▶$41MraisedOct 2020 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Keith VendolaExecutive Officer
- Young-Jin KimDirector
- Jung-Hee LimDirector
- Philippe FauchetDirector
- Sankaram MantripragadaExecutive Officer
- Nevan Charles ElamExecutive Officer, Director
- Gil LabrucherieDirector
- Offering amount
- $57M
- Amount sold
- $41M
- Sales commissions
- $2.5M
- Placement agents
- Griffin Securities, Inc., JMP Securities LLC, Canaccord Genuity LLC
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.8MraisedApr 2018 · 34 investors · BiotechnologyRule 506(b)
▶$4.8MraisedApr 2018 · 34 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David F. WelchDirector
- Hoyoung HuhExecutive Officer, Director
- Gil LabrucherieDirector
- Sankaram MantripragadaExecutive Officer
- Morgan Lynn FieldsExecutive Officer
- Tae Hoon KimDirector
- Brian RobertsExecutive Officer
- Noopur Batsha LiffickExecutive Officer
- Michael R. DeperroExecutive Officer
- Samir R. PatelDirector
- Nevan Charles ElamExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $4.8M
- Sales commissions
- $202.3K
- Placement agents
- Brookline Capital Markets, a division of CIM Securities, LLC
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.4MraisedFeb 2018 · 190 investors · BiotechnologyRule 506(b)
▶$3.4MraisedFeb 2018 · 190 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tae Hoon KimDirector
- Gil LabrucherieDirector
- Nevan Charles ElamExecutive Officer, Director
- Morgan Lynn FieldsExecutive Officer
- Hoyoung HuhExecutive Officer, Director
- David F. WelchDirector
- Michael R. DeperroExecutive Officer
- Samir R. PatelDirector
- Noopur Batsha LiffickExecutive Officer
- Sankaram MantripragadaExecutive Officer
- Brian RobertsExecutive Officer
- Offering amount
- $25.4M
- Amount sold
- $3.4M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$137.9KraisedJan 2018 · 1 investors · BiotechnologyRule 506(b)
▶$137.9KraisedJan 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tae Hoon KimDirector
- Sankaram MantripragadaExecutive Officer
- David F. WelchDirector
- Brian RobertsExecutive Officer
- Michael R. DeperroExecutive Officer
- Noopur Batsha LiffickExecutive Officer
- Samir R. PatelDirector
- Hoyoung HuhExecutive Officer, Director
- Gil LabrucherieDirector
- Nevan Charles ElamExecutive Officer, Director
- Morgan Lynn FieldsExecutive Officer
- Offering amount
- $10.1M
- Amount sold
- $137.9K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.7MraisedMay 2017 · 5 investors · BiotechnologyRule 506(b)
▶$6.7MraisedMay 2017 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nevan Charles ElamExecutive Officer, Director
- Tae Hoon KimDirector
- Brian RobertsExecutive Officer
- Sankaram MantripragadaExecutive Officer
- David F. WelchDirector
- Morgan Lynn FieldsExecutive Officer
- Barry ShermanDirector
- Michael R. DeperroExecutive Officer
- Samir R. PatelDirector
- Noopur Batsha LiffickExecutive Officer
- Hoyoung HuhExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $6.7M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.4MraisedJul 2016 · 60 investors · BiotechnologyRule 506(b)
▶$5.4MraisedJul 2016 · 60 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hoyoung HuhExecutive Officer, Director
- Morgan Lynn FieldsExecutive Officer
- David WelchDirector
- Sankaram MantripragadaExecutive Officer
- Barry ShermanDirector
- Nevan Charles ElamExecutive Officer, Director
- Offering amount
- $53.3M
- Amount sold
- $5.4M
- Sales commissions
- $2M
- Placement agents
- CIM Securities, LLC, Paulson Investment Company, Inc.
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.3MraisedMar 2016 · 11 investors · BiotechnologyRule 506(b)
▶$4.3MraisedMar 2016 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Barry ShermanDirector
- Morgan Lynn FieldsExecutive Officer
- Nevan Charles ElamExecutive Officer, Director
- Hoyoung HuhExecutive Officer, Director
- Sankaram MantripragadaExecutive Officer
- David WelchDirector
- Offering amount
- $16.7M
- Amount sold
- $4.3M
- Sales commissions
- $737.5K
- Placement agents
- CIM Securities, LLC, Brookline Group, LLC
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedApr 2015 · 14 investors · BiotechnologyRule 506(b)
▶$2MraisedApr 2015 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Barry ShermanDirector
- Hoyoung HuhDirector, Executive Officer
- Morgan Lynn FieldsExecutive Officer
- Nevan Charles ElamExecutive Officer, Director
- Sankaram MantripragadaExecutive Officer
- Offering amount
- $4.7M
- Amount sold
- $2M
- Sales commissions
- $98.4K
- Placement agents
- Paulson Investment Company, Inc.
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.